demonstrated that FTO played an important role in promoting melanoma tumorigenesis and anti-PD-1 resistance, and the combination of FTO inhibitors with anti-PD-1 blockers could reduce the resistance to immunotherapy in melanoma (15). Here, FTO is linked to melanoma.